[Certain possible complications and side effects after the introduction of interleukin-2 in the scheme of treatment of surgical patients].
Maĭborodin
I V
IV
Shevela
A I
AI
Egorov
D V
DV
Strel'tsova
E I
EI
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004333:Drug Administration Routes; D004342:Drug Hypersensitivity; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D013530:Surgical Wound Infection / Q000188:drug therapy*
D000970:Antineoplastic Agents; D007376:Interleukin-2; D011994:Recombinant Proteins